Delivery Order SPE2DR25D9223-SPE2DR26FFAD9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,796.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30S. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 15, 2025, and no set-aside designation was utilized. Performance will take place in Park Ridge, Illinois, with funding provided by the Defense...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,932.89 to DMS Pharmaceutical Group Inc. for Lidocaine 5% Patch 30s, with an ultimate completion date of October 20, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The delivery order will be performed in...
- The Defense Logistics Agency awarded a delivery order valued at $3,164.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30s. The award, made on August 21, 2025, with an ultimate completion date of August 22, 2025, was issued under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,183.16 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30s. This delivery order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, carries no set-aside designation and represents a standard procurement vehicle under DLA's pharmaceutical supply operations. The award leverages DMS...
- The Defense Logistics Agency awarded a delivery order valued at $7,733.94 to DMS Pharmaceutical Group Inc. for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of September 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,481 to DMS Pharmaceutical Group Inc. for 30 units of Lidocaine 5% Patch on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, serves as the prime contractor on this order. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,074.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30s. This firm fixed-price delivery order was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the contractor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch in quantities of 30 units. The contract is valued at $4,303.04 with a firm fixed-price structure and is scheduled for completion by August 26, 2025. This delivery order was issued without a set-aside designation, and the place of performance is Park Ridge, Illinois. This delivery order is...
- This is a $7,593.60 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of 4,563,767,512 units of Lidocaine 5% Patch 30s, with a completion date of February 27, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,034.38 firm fixed-price delivery order is for the supply of Lidocaine 5% Patches to support the recurring medical supply needs of military health facilities. The award is associated with a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA...
- SPE2DR25D9223Indefinite Delivery Contract
- SPE2DR25D9223-SPE2DR26FFAD9Delivery Order
The Defense Logistics Agency awarded a $1,461.84 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30S. The award, issued on January 27, 2026, with an ultimate completion date of January 28, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy through which the Defense Logistics Agency establishes multiple regional prime vendor contractors to supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's selection as a prime vendor contractor reflects its established performance in supplying a comprehensive range of pharmaceuticals including branded and generic prescription drugs, biologics, vaccines, and specialty pharmaceuticals to military healthcare facilities. The company's demonstrated contracting activity and expertise across diverse therapeutic categories position it as a critical supplier within the federal military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 1/26/26 |